3644 results for «2757»

Filter By

3644 results

New insights in coronary atherosclerosis using intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...

Optimising TAVI care pathways

21 May 2026 – From EuroPCR 2026

This session examines innovations in TAVI care pathways aimed at improving patient outcomes and healthcare efficiency. Topics include large-scale transatlantic data on day-case TAVI, standardized ECG conduction algorithms reducing hospital stay, nurse-led structured pathways, feasibility of very early discharge, and urgent outpatient TAVI for severe aortic...

Increasing efficiency in CTO PCI

21 May 2026 – From EuroPCR 2026

Focused on increasing efficiency in CTO PCI, this session covers diverse technical approaches including overcoming unexpected anatomical barriers, multiple wiring techniques, microchannel selection in bifurcation lesions, managing tortuous right coronary artery CTOs, unconventional strategies for uncrossable CTOs, and adapting perspectives in patients with previous CABG.

Optimising the results of non-left main bifurcation PCI

21 May 2026 – From EuroPCR 2026

This session focuses on optimizing outcomes in non-left main bifurcation PCI by emphasizing lesion preparation and stent sizing guided by intravascular imaging. It integrates physiological and imaging assessments for confident final result evaluation and discusses criteria for selecting upfront two-stent strategies in bifurcation lesions.

Optimising the results of non-left main bifurcation PCI

Advancing TAVI practice

21 May 2026 – From EuroPCR 2026

Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.

Advancing TAVI practice

TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more

21 May 2026 – From EuroPCR 2026

This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.

TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more

TAVI - Procedural strategy

21 May 2026 – From EuroPCR 2026

This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in...

TAVI - Procedural strategy

Is DCB the new gold standard for side branch treatment in bifurcation?

21 May 2026 – From EuroPCR 2026

This session explores the emerging role of drug-coated balloons (DCB) as a potential new standard for side branch treatment in bifurcation lesions. It focuses on selecting appropriate indications, optimal vessel preparation and delivery timing, and executing stepwise DCB strategies versus hybrid approaches to maximize clinical outcomes.

Is DCB the new gold standard for side branch treatment in bifurcation?

Publishing in interventional cardiology: aligning authors, editors and impact

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.

Beyond the diagnosis: a qualitative exploration of women’s experiences with cardiovascular disease

21 May 2026 – From EuroPCR 2026

This session presents a qualitative exploration of women's experiences with cardiovascular disease, highlighting unique challenges throughout their care pathway from diagnosis to rehabilitation. It shares robust patient experience data and offers recommendations aimed at improving cardiovascular care tailored to women’s specific needs.

Beyond the diagnosis: a qualitative exploration of women’s experiences with cardiovascular disease

Precision TAVI - Seering marginal gains

21 May 2026 – From EuroPCR 2026

This session delves into precision techniques in transcatheter aortic valve implantation (TAVI), highlighting novel stepwise implantation methods for self-expanding valves, the effects of internal diameter and valve fracture on gradients post valve-in-valve TAVI, and comparative analyses of implantation-depth variability across large-size TAVI platforms. Additionally, it evaluates...

TAVI procedural complications - Part 8: aortic dissection, multiple valves procedures, and more

21 May 2026 – From EuroPCR 2026

This session addresses complex procedural complications encountered during TAVI, featuring challenging cases such as aortic dissection, multiple valve procedures including redo TAVI in patients with left ventricular assist devices, and structural failures like valve infolding and embolisation. It emphasizes strategic decision-making under critical circumstances to optimize...

Risk and prognosis predictors in STEMI

21 May 2026 – From EuroPCR 2026

This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...

Primary PCI dilemmas: when imaging saves the day

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of imaging in resolving dilemmas during primary percutaneous coronary intervention (PCI). It presents complex cases illustrating challenges such as coronary compression, thrombus burden in large vessels, and culprit lesion identification, including the use of high-definition intravascular ultrasound (HD-IVUS) to reclassify...

Advanced mitral TEER strategies in complex clinical scenarios

20 May 2026 – From EuroPCR 2026

This session presents advanced strategies for mitral transcatheter edge-to-edge repair (TEER) in complex clinical settings. Through cases involving surgical ring dehiscence, acute mitral regurgitation, dextrocardia, congenital anomalies, severe annular calcifications, and creative procedural approaches, it explores the expanding role of TEER. The session provides guidance on...

Interventions for hypertension: latest developments

20 May 2026 – From EuroPCR 2026

This session reviews the latest developments in interventional treatments for hypertension, focusing on renal denervation (RDN) technologies and clinical outcomes. It includes comparative procedural data from global registries and studies, novel computational assessments, and applications in specific patient populations such as those with polycystic kidney disease...

Tough scenarios in multivessel disease

20 May 2026 – From EuroPCR 2026

This session addresses challenging scenarios in multivessel coronary artery disease (CAD), particularly when surgical options are limited. Case discussions include IVUS-guided PCI with rotational atherectomy, management of combined severe aortic stenosis and multivessel disease, acute mitral regurgitation with cardiogenic shock, anomalous coronary anatomy, severe kidney disease,...

TAVI: alternative access

17 Nov 2025 – From PCR London Valves 2025

This session addresses alternative access routes for TAVI in patients with challenging vascular anatomies. It includes innovative approaches such as transapical TAV-in-TAV procedures, transcaval implantation in emergency settings, and techniques for patients with hostile iliofemoral access, showcasing adaptive strategies when conventional access is not feasible.

Challenging TAVI

16 Nov 2025 – From PCR London Valves 2025

This session addresses the complexities encountered in transcatheter aortic valve implantation (TAVI) in challenging anatomical settings. It reviews management of bicuspid valves with calcification, horizontal aorta, coronary artery anomalies, and navigation of difficult angles. Case studies illustrate techniques to optimize commissural alignment and strategies to address...

TAVI: challenging anatomies

17 Nov 2025 – From PCR London Valves 2025

This session explores the management of challenging anatomical conditions in TAVI procedures. Topics include strategies for difficult self-expandable valve delivery angles, addressing complications occurring during and after TAVI, and approaches for patients with severe kyphosis or complex structural abnormalities such as aneurysms and septal anomalies.

Didn’t find what you were looking for?